New data published in Atherosclerosis shows a 25% reduction in CVD risk when patients are managed to an LDL-P goal. See the press release. Read the study.
The NMR LipoProfile® test A clinically reliable measure of LDL

Improving Patient Care One Patient at a Time

The NMR LipoProfile® test is an FDA-cleared blood test that directly quantifies low density lipoprotein particles (LDL-P) circulating in the body. LDL-P by NMR is a more clinically reliable measure of LDL used to manage patients with increased CVD risk.

Why Measure LDL with LDL-P by NMR

"LDL" stands for low density lipoprotein, a particle that carries cholesterol in the body. LDL is a well-established, causal risk factor for the development of cardiovascular disease (CVD). Additionally, lowering LDL is a central treatment strategy for reducing cardiovascular risk in clinical practice.In order to be effectively managed, LDL levels must be reliably measured. There are two ways to measure LDL, LDL cholesterol (LDL-C) and LDL particle number (LDL-P). Although the medical field has acknowledged LDL particles as the driving force behind plaque buildup in the arteries since the 1950s, a diagnostic test did not exist to measure LDL particle number (LDL-P). As a result, LDL-C was adopted for as the measure of LDL quantity. Today, a more clinically reliable measure of LDL exists that directly counts the number of LDL particles a patient has using NMR technology. Clinical studies show that LDL-P by NMR is the more clinically reliable measure of LDL allowing doctors to thoroughly manage LDL-related risk for heart disease.

Learn More about the NMR LipoProfile test

Health Care Providers Patients